News Focus
News Focus
icon url

DewDiligence

01/09/17 10:14 AM

#207767 RE: Titan V #207764

INCY +5%, suggesting investors see Keytruda/Epacadostat as one of the leading (perhaps the leading) I-O regimens in development.